Hassman Research Institute   Report issue

For profit Phase 4
Founded: Berlin NJ United States (2016)
Status: Acquired by Apex Innovative Sciences, Inc. (2019)

Organization Overview

First Clinical Trial
2019
NCT03993392
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Hassman Research Institute

Active Ingredients

Drugs in Phase 4 Trials (1)

buprenorphine (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Disease (Phase 4)

Substance-Related Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 1